Brain PET-MRI Systems Market Size & Growth Forecast 2027–2036, By Segments (Phase, Product, End-use), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Brain PET-MRI Systems Market size was valued at USD 398.87 million in 2026 and is projected to grow at a 5.7% CAGR from 2027 to 2036, attaining USD 694.35 million by 2036. The industry revenue for 2027 is estimated at USD 418.02 million.
Get more details on this report
Request Free Sample ReportBrain PET-MRI Systems Market Intelligence Snapshot
Regional Market Dynamics
- North America held a 32.22% market share in 2026, supported by advanced diagnostic imaging infrastructure, widespread use of multimodal neuroimaging, and strong deployment across hospitals, research centers, and specialized imaging facilities.
- Asia Pacific is projected to grow at a 6.89% CAGR as healthcare providers expand advanced imaging capacity, invest in modern diagnostic equipment, and improve access to specialized neurological evaluation.
Segment Momentum
- Pre-clinical leads with 60.9% due to strong use in neuroscience research, translational studies, and established experimental imaging workflows requiring integrated PET-MRI for controlled studies and long development cycles.
- Helium-free PET-MRI systems are fastest-growing due to reduced reliance on helium cooling, lower operational constraints, improved sustainability, and easier long-term maintenance, supporting broader adoption in clinical and research facilities.
Market Expansion Drivers
- Growing adoption of hybrid neuroimaging systems improving functional and structural brain diagnostics.
- Rising demand for ultra-high-resolution imaging enhancing neurological research and diagnosis precision.
- Increasing clinical integration of multiparametric imaging for early detection of neurological disorders.
Leading Market Participants
- Major players in the brain PET-MRI systems market include Siemens Healthineers AG (Germany), GE HealthCare Technologies Inc. (United States), Koninklijke Philips N.V. (Netherlands), Mediso Ltd. (Hungary), MR Solutions Ltd. (United Kingdom), Cubresa Inc. (Canada), United Imaging Healthcare Co., Ltd. (China).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 398.87 million
- 2027 Estimated Market Size: USD 418.02 million.
- Projected Market Size: USD 694.35 million by 2036
- Growth Forecast: 5.7% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Pre-clinical (Phase) | Traditional PET-MRI Systems (Product) | Hospitals (End-use)
- Emerging Opportunity Segment: Clinical (Phase) | Helium-free PET-MRI Systems (Product) | Diagnostic Imaging Centers (End-use)
Market Growth Drivers and Industry Trends
Growing adoption of hybrid neuroimaging systems improving functional and structural brain diagnostics
The growing use of hybrid neuroimaging is supporting the brain PET-MRI systems market by combining metabolic and molecular information from PET with detailed anatomical and functional information from MRI within a coordinated imaging workflow. This integrated approach allows clinicians and researchers to examine brain structure alongside biological activity, supporting more comprehensive assessment of neurological abnormalities. The ability to correlate complementary imaging information can improve interpretation in complex neurological conditions and reduce the need to rely on separate examinations when multiple forms of brain characterization are required, making hybrid systems increasingly relevant in advanced diagnostic and research settings.
Rising demand for ultra-high-resolution imaging enhancing neurological research and diagnosis precision
Demand for highly detailed brain imaging is contributing to the brain PET-MRI systems market as clinicians and researchers seek greater precision when evaluating subtle neurological changes. Advanced MRI capabilities can provide detailed visualization of brain structures, while PET contributes information on metabolic or molecular processes that may not be apparent through anatomical imaging alone. Higher-resolution imaging can support more precise localization and characterization of abnormalities, assist researchers in investigating disease mechanisms, and strengthen the evaluation of neurological conditions where small structural or functional differences can influence diagnostic assessment.
Increasing clinical integration of multiparametric imaging for early detection of neurological disorders
Multiparametric imaging is expanding the clinical role of the brain PET-MRI systems market by allowing several complementary characteristics of neurological disorders to be evaluated within an integrated imaging framework. Combining anatomical, functional, metabolic, and molecular information can provide clinicians with a broader view of disease-related changes and support differentiation between conditions with overlapping clinical presentations. Earlier identification of abnormalities can also benefit from the ability to assess multiple imaging biomarkers together, particularly when disease-related changes may emerge across different biological dimensions before becoming clearly evident through a single imaging technique.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Growing adoption of hybrid neuroimaging systems improving functional and structural brain diagnostics | 2.30% | High | North America, Europe | Medium | Mid Term |
| Rising demand for ultra-high-resolution imaging enhancing neurological research and diagnosis precision | 2.00% | Moderate | North America, Europe, Asia Pacific | Emerging | Mid Term |
| Increasing clinical integration of multiparametric imaging for early detection of neurological disorders | 1.80% | High | North America, Europe | Medium | Long Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
The brain PET-MRI systems market in North America accounted for a 32.22% share in 2026, reflecting the region's advanced neuroimaging infrastructure, strong research capabilities, and established use of sophisticated diagnostic technologies. PET-MRI combines metabolic and anatomical information, making it valuable for investigating complex neurological disorders and supporting research into brain function and disease progression. Leading academic and clinical institutions continue to invest in advanced imaging capabilities, while growing interest in precision diagnosis is supporting demand for multimodal systems. Integration of imaging data with specialized neurological care and research programs further strengthens North America's position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is witnessing the fastest growth as healthcare systems expand their advanced imaging capabilities and investment in neurological diagnostics increases. Greater awareness of neurodegenerative disorders and the importance of early, accurate diagnosis is encouraging healthcare institutions to adopt sophisticated imaging platforms. Improvements in medical infrastructure, specialist expertise, and access to advanced diagnostic services are also creating a more favorable environment for PET-MRI deployment. In addition, growing clinical research activity and increasing healthcare expenditure are supporting adoption of multimodal imaging technologies across major healthcare markets.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Clinical Imaging IntegrationGermany emphasizes brain PET-MRI systems that strengthen collaboration between university hospitals and imaging specialists. Procurement focuses on improving diagnostic confidence while supporting multidisciplinary neuroscience and oncology programs.
France 🇫🇷
Translational Imaging FocusFrance promotes brain PET-MRI systems within research-driven healthcare networks focused on neurological and oncological applications. Investment supports collaboration between clinical practice and translational research to enhance diagnostic workflows.
Italy 🇮🇹
Specialized Imaging InvestmentItaly focuses on brain PET-MRI systems for specialized hospitals seeking comprehensive neurological imaging capabilities. Healthcare providers value systems that improve clinical efficiency while supporting complex diagnostic case management.
Japan 🇯🇵
Precision Brain DiagnosticsJapan advances brain PET-MRI systems through strong interest in neurodegenerative disease assessment and high-quality imaging performance. Healthcare providers seek technologies that improve diagnostic accuracy while fitting established hospital imaging infrastructure.
South Korea 🇰🇷
Research Hospital ExpansionSouth Korea expands adoption of brain PET-MRI systems across major research hospitals investing in advanced diagnostic capabilities. Clinical institutions prioritize integrated imaging platforms that support neuroscience innovation and personalized treatment planning.
United States 🇺🇸
Advanced Neuroimaging AdoptionThe U.S. prioritizes brain PET-MRI systems for neurological research, precision diagnostics, and academic medical centers. Demand is supported by integration with advanced imaging workflows and increasing emphasis on early detection of complex brain disorders.
Segment Leadership and Growth Trends
Brain PET-MRI Systems Market Share (%), by Phase, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportPhase Segment Analysis: Pre-clinical (Largest Segment) vs Clinical (Fastest-Growing Segment)
The pre-clinical segment dominated the brain PET-MRI systems market with a 60.9% share in 2026, supported by the value of integrated imaging in neuroscience research and disease-model evaluation. PET-MRI combines functional and anatomical information, allowing researchers to investigate neurological processes while obtaining complementary imaging insights within the same examination framework. Its application in experimental research, biomarker investigation, and development of improved approaches to neurological disease assessment continues to sustain demand in pre-clinical environments.
Clinical applications are gaining momentum as healthcare providers increasingly recognize the potential of combined PET and MRI imaging for comprehensive neurological assessment. Integrated imaging can support the evaluation of brain structure alongside metabolic and functional information, which is valuable for complex neurological and oncological investigations. Growing interest in precision diagnostics, advanced imaging workflows, and more detailed disease characterization is supporting broader clinical adoption.
Product Segment Analysis: Traditional PET-MRI Systems (Largest Segment) vs Helium-free PET-MRI Systems (Fastest-Growing Segment)
Traditional PET-MRI systems held the largest share of the brain PET-MRI systems market, accounting for 58.59% in 2026. Their established position is supported by existing clinical and research infrastructure, familiarity among imaging professionals, and the broad availability of conventional integrated imaging configurations. These systems provide combined anatomical and functional imaging capabilities, making them valuable for neurological research and advanced diagnostic applications where complementary information is required.
Helium-free PET-MRI systems are emerging as the fastest-growing product segment, supported by interest in imaging platforms that can reduce dependence on conventional helium-based cooling infrastructure. Their operational design can improve installation flexibility and address practical considerations associated with system maintenance and facility requirements. As imaging centers and research institutions seek more efficient and adaptable advanced imaging technologies, helium-free configurations are gaining attention as an evolving solution within the PET-MRI landscape.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| Phase | Clinical, Pre-clinical | Pre-clinical | Clinical |
| Product | Traditional PET-MRI Systems, Helium-free PET-MRI Systems | Traditional PET-MRI Systems | Helium-free PET-MRI Systems |
| End-use | Hospitals, Diagnostic Imaging Centers, Others | Hospitals | Diagnostic Imaging Centers |
Competitive Landscape and Market Positioning
Prominent players in the brain PET-MRI systems market:
1. Siemens Healthineers AG (Germany)
2. GE HealthCare Technologies Inc. (United States)
3. Koninklijke Philips N.V. (Netherlands)
4. Mediso Ltd. (Hungary)
5. MR Solutions Ltd. (United Kingdom)
6. Cubresa Inc. (Canada)
7. United Imaging Healthcare Co. Ltd. (China)
The brain PET-MRI systems market is advancing through integration of hybrid imaging technologies that improve neurological diagnostic precision. Continuous innovation is enhancing image resolution and functional analysis capabilities. Collaborative research efforts are strengthening multimodal imaging applications in neuroscience.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Siemens Healthineers AG (Germany) | |||||||
| GE HealthCare Technologies Inc. (United States) | |||||||
| Koninklijke Philips N.V. (Netherlands) | |||||||
| Mediso Ltd. (Hungary) | |||||||
| MR Solutions Ltd. (United Kingdom) | |||||||
| Cubresa Inc. (Canada) | |||||||
| United Imaging Healthcare Co. Ltd. (China). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| GE HealthCare | May-24 | GE HealthCare introduced SIGNA MAGNUS, a head-only MRI system designed to advance neuroscience research and improve understanding of brain structure and function. The system is positioned to support research into psychiatric and neurological disorders by enabling higher-resolution imaging and more targeted investigation of complex brain conditions in clinical and research environments. |
| Philips | Feb-24 | Philips launched Smart Quant Neuro 3D, an AI-based quantitative brain MRI software solution aimed at improving diagnostic confidence and workflow efficiency. The solution enhances image interpretation capabilities in neuroimaging by providing advanced quantitative tools for more precise assessment of neurological conditions. |
| GE HealthCare | Jun-23 | GE HealthCare unveiled SIGNA PET/MRI AIR technologies at the Society of Nuclear Medicine and Molecular Imaging annual meeting, introducing enhancements to hybrid imaging performance. The development strengthens its PET-MRI portfolio by improving image quality and system integration for advanced neuroimaging applications in clinical and research settings. |
| Cubresa | May-23 | Cubresa installed its first BrainPET insert system at St. Joseph’s Health Care London in collaboration with Lawson Health Research Institute. The installation validates the system in a real-world research environment and supports advancement of hybrid brain imaging technologies by enabling integrated PET-MRI research applications. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Brain PET-MRI Systems Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Clinical Application | Neurological Disorders, Neurodegenerative Diseases, Brain Tumor Imaging, Epilepsy & Seizure Disorders, Research & Drug Development |
| System Mobility | Fixed Systems, Mobile Systems, Portable/Compact Systems |
| Procurement Model | Direct Purchase, Capital Equipment Leasing, Pay-per-Use & Managed Imaging Services |
Brain PET-MRI Systems Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Clinical Adoption Pathway Analysis |
|
| Neurological Research Application Opportunities |
|
| Advanced Neuroimaging Innovation Landscape |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market valuation of brain PET-MRI systems?
What is the projected value of the brain PET-MRI systems industry by 2036?
How is the adoption of hybrid PET-MRI systems reshaping clinical workflow and procurement strategies in neurology centers?
What is driving increased demand for ultra-high-resolution and multiparametric brain imaging in clinical and research settings?
Why does the Pre-clinical phase dominate the brain PET-MRI systems market?
What is driving growth in Helium-free PET-MRI systems?
Why does North America lead the brain PET-MRI systems market?
What is driving growth in the brain PET-MRI systems market across Asia Pacific?
Which companies dominate the brain PET-MRI systems landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization